Belsky Marc 4
4 · Kezar Life Sciences, Inc. · Filed Jan 10, 2023
Insider Transaction Report
Form 4
Belsky Marc
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-08+195,000→ 195,000 totalExercise: $6.84Exp: 2033-01-07→ Common Stock (195,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 8, 2023, subject to the Reporting Person continuing to provide service through each such date.